Traws Pharma Files 8-K on Financials
Ticker: TRAW · Form: 8-K · Filed: Aug 15, 2024 · CIK: 1130598
| Field | Detail |
|---|---|
| Company | Traws Pharma, Inc. (TRAW) |
| Form Type | 8-K |
| Filed Date | Aug 15, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, company-update
TL;DR
Traws Pharma dropped an 8-K on financials, check it out.
AI Summary
Traws Pharma, Inc. filed an 8-K on August 15, 2024, reporting on its results of operations and financial condition. The filing also includes financial statements and exhibits. The company was formerly known as Onconova Therapeutics, Inc. and is incorporated in Delaware.
Why It Matters
This 8-K filing provides an update on Traws Pharma's financial status and operational results, which is crucial for investors to assess the company's performance and future prospects.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of financial information and does not indicate any immediate or significant risks.
Key Players & Entities
- Traws Pharma, Inc. (company) — Registrant
- Onconova Therapeutics, Inc. (company) — Former company name
- August 15, 2024 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 12 Penns Trail Newtown, PA 18940 (address) — Business address
FAQ
What is the primary purpose of this 8-K filing by Traws Pharma, Inc.?
The primary purpose of this 8-K filing is to report on Traws Pharma, Inc.'s results of operations and financial condition, and to include financial statements and exhibits.
When was the earliest event reported in this filing?
The earliest event reported in this filing occurred on August 15, 2024.
What was Traws Pharma, Inc. formerly known as?
Traws Pharma, Inc. was formerly known as Onconova Therapeutics, Inc.
In which state is Traws Pharma, Inc. incorporated?
Traws Pharma, Inc. is incorporated in Delaware.
What is the business address of Traws Pharma, Inc. as listed in the filing?
The business address of Traws Pharma, Inc. is 12 Penns Trail, Newtown, PA 18940.
Filing Stats: 459 words · 2 min read · ~2 pages · Grade level 10.6 · Accepted 2024-08-15 07:30:26
Filing Documents
- tm2421727d1_8k.htm (8-K) — 23KB
- tm2421727d1_ex99-1.htm (EX-99.1) — 69KB
- 0001104659-24-089914.txt ( ) — 269KB
- tmb-20240815.xsd (EX-101.SCH) — 3KB
- tmb-20240815_lab.xml (EX-101.LAB) — 33KB
- tmb-20240815_pre.xml (EX-101.PRE) — 22KB
- tm2421727d1_8k_htm.xml (XML) — 4KB
02 Results of Operations and Financial Condition
Item 2.02 Results of Operations and Financial Condition. On August 15, 2024, Traws Pharma, Inc. (the "Company") issued a press release announcing its financial results for the quarter ended June 30, 2024, a copy of which is attached hereto as Exhibit 99.1 and incorporated herein by reference. The information contained in this Form 8-K (including the exhibit hereto) shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Exhibit 99.1 Press release issued by the Company dated August 15, 2024 104 The cover page from this Current Report on Form 8-K, formatted in Inline XBRL.
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. TRAWS PHARMA, Inc. Date: August 15, 2024 By: /s/ MARK GUERIN Mark Guerin Chief Financial Officer